Literature DB >> 4727456

Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects.

D Rudman, T J DiFulco, J T Galambos, R B Smith, A A Salam, W D Warren.   

Abstract

When normal individuals eat 0.33 g protein N/kg body weight (BW)((3/4)) per day, they excrete 10-15 mg urea N/h per kg BW((3/4)). If they now ingest (at 0 h) 0.27 (dose A), 0.40 (dose B), 0.53 (dose C), 0.94 (dose D), or 1.33 (dose E) g protein N/kg BW((3/4)) (in the form of casein, ovalbumin, or lactalbumin), the rate of urea N excretion accelerates within 4 h. At dose C a maximal rate of urinary urea N excretion (MRUE) is reached, which averages 55 mg urea N/h per kg BW((3/4)) and which persists for 16 h. Higher doses of protein do not further accelerate urea excretion, but prolong the duration of MRUE to 28 h (after dose E). Blood urea N (BUN) rises by 7-20 mg/100 ml during the first 8 h after dose C to E, and remains stable within +/-5 mg/100 ml during the ensuing 8-28 h of MRUE. Each increment of protein above dose C causes a further increment in plasma alpha-amino N. During infusion of free amino acids at a rate of 110 or 165 mg amino acid N/h per kg BW((3/4)) for 12 h, rate of urea excretion increases to the MRUE value produced by dose C-E of oral protein.These findings indicate that MRUE corresponds to a period of maximal rate of urea synthesis (MRUS). MRUS is greater than MRUE because one fraction of newly formed urea is hydrolyzed in the gastrointestinal tract, and another fraction may accumulate temporarily in body water during the MRUE period. Oral neomycin reduces the proportion of urea hydrolyzed in the gut to less than 20%; its extent is measured by recovery in the urine of a tracer dose of [(14)C]urea injected intramuscularly during determination of MRUE. Accumulation of urea in body water is estimated from increment in BUN during the period of MRUE measurement (8-24 h after dose E of casein) and from body water measured with (3)H(2)O. Then MRUS is calculated as: ([mg urea N excreted between 8 and 24 h after dose E] + [BUN at 24 h - BUN at 8 h] x [body water]) x (100/% recovery [(14)C]urea) x (1/kg BW((3/4))) x (1/16 h).MRUS in 10 normal subjects averaged 65 mg urea N/h per kg BW((3/4)) (range 55-76), and in 34 cirrhotics 27 mg urea N/h per kg BW((3/4)) (range 6-64). Among 19 cirrhotic patients fed 40, 60, 80, or 100 g protein daily for successive 10 day periods, the occurrences of hyperammonemia, hyperaminoacidemia, and encephalopathy at each level of protein intake were inversely related to MRUS value.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4727456      PMCID: PMC333026          DOI: 10.1172/JCI107410

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  10 in total

1.  EXPERIMENTAL COMPARISON OF THE RATES AND VOLUMES OF DISTRIBUTION OF UREA, CREATININE, N-ACETYL-4-AMINOPHENAZONE, AND TRITIATED WATER.

Authors:  R E WILLIAMS; A H SMITH; G A YOUNG; F M PARSONS; G W REED
Journal:  Br J Surg       Date:  1964-07       Impact factor: 6.939

2.  Urea metabolism in man.

Authors:  M WALSER; L J BODENLOS
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

3.  Estimation of total body water (virtual tritium space) in the rat, cat, rabbit, guinea-pig and man, and of the biological half-life of tritium in man.

Authors:  J M FOY; H SCHNIEDEN
Journal:  J Physiol       Date:  1960-11       Impact factor: 5.182

4.  An automatic method for colorimetric analysis.

Authors:  L T SKEGGS
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

5.  The electroencephalograph in liver disease.

Authors:  B G PARSONS-SMITH; W H SUMMERSKILL; A M DAWSON; S SHERLOCK
Journal:  Lancet       Date:  1957-11-02       Impact factor: 79.321

6.  Determination of urea nitrogen with the diacetyl method and an automatic dialyzing apparatus.

Authors:  W H MARSH; B FINGERHUT; E KIRSCH
Journal:  Am J Clin Pathol       Date:  1957-12       Impact factor: 2.493

7.  Studies of total body water with tritium.

Authors:  T C PRENTICE; W SIRI; N I BERLIN; G M HYDE; R J PARSONS; E E JOINER; J H LAWRENCE
Journal:  J Clin Invest       Date:  1952-04       Impact factor: 14.808

8.  Hemodynamic contrasts between selective and total portal-systemic decompression.

Authors:  A A Salam; W D Warren; J R LePage; M R Viamonte; D Hutson; R Zeppa
Journal:  Ann Surg       Date:  1971-05       Impact factor: 12.969

9.  Urea metabolism and distribution in rabbits treated with neomycin.

Authors:  J E McKinley; D B Gilbert; P Y Chao; E B Reeve
Journal:  Am J Physiol       Date:  1970-02

10.  Observations on the nitrogen metabolism of patients with portal cirrhosis.

Authors:  D Rudman; S Akgun; J T Galambos; A S McKinney; A B Cullen; G G Gerron; C H Howard
Journal:  Am J Clin Nutr       Date:  1970-09       Impact factor: 7.045

  10 in total
  35 in total

1.  Portal hypertension. A new beginning for an old problem.

Authors:  J T Galambos; D Rudman; W D Warren
Journal:  Am J Dig Dis       Date:  1976-09

2.  Formation and characterization of three dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications.

Authors:  Poonam Verma; Vipin Verma; Pratima Ray; Alok R Ray
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-20       Impact factor: 2.416

3.  Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.

Authors:  Avinash Kumar; Gangarao Davuluri; Rafaella Nascimento E Silva; Marielle P K J Engelen; Gabrie A M Ten Have; Richard Prayson; Nicolaas E P Deutz; Srinivasan Dasarathy
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

4.  Ammonium and bicarbonate homeostasis in chronic liver disease.

Authors:  D Häussinger; R Steeb; W Gerok
Journal:  Klin Wochenschr       Date:  1990-02-01

5.  The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis.

Authors:  R Carlisle; J T Galambos; W D Warren
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

6.  The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts.

Authors:  W D Warren; D Rudman; W Millikan; J T Galambos; A A Salam; R B Smith
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

7.  A randomized, controlled trial of the distal splenorenal shunt.

Authors:  L F Rikkers; D Rudman; J T Galambos; J T Fulenwider; W J Millikan; M Kutner; R B Smith; A A Salam; P J Sones; W D Warren
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

8.  The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up.

Authors:  W J Millikan; W D Warren; J M Henderson; R B Smith; A A Salam; J T Galambos; M H Kutner; J H Keen
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

9.  Nutrition and muscle protein synthesis: a descriptive review.

Authors:  Dan J Weinert
Journal:  J Can Chiropr Assoc       Date:  2009-08

10.  [Results of the distal splenorenal Warren shunt (author's transl)].

Authors:  J M Funovics; A Fritsch; W H Appel; F Mühlbacher
Journal:  Langenbecks Arch Chir       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.